End-of-life Decision-makingNCT06551831
End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach
An observational study of End-of-life Decision-making, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
The purpose of this qualitative research is to use grounded theory to explore and describe the thoughts of young advanced cancer patients regarding end-of-life care and how these thoughts influence the related decision-making process. Read more about this study
- Who is it for?
- Ages 18 to 39 years
- Conditions the study is for
- End-of-life Decision-making
- How many people
- 30 participants
- Where
- 1 siteTaiwan
- Study dates
- 23 Jul 2024to Jul 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 39 years
- All sexes
- No healthy volunteers
- Adult
Study population: * The patient has a solid tumor. * The age at initial cancer diagnosis is between 15 and 39 years. * The patient is at least 18 years old at the time of enrollment. * The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up. * After metastasis, the first-line curative treatment is ineffective.
Who may be able to join
- The patient has a solid tumor.
- The age at initial cancer diagnosis is between 15 and 39 years.
- The patient is at least 18 years old at the time of enrollment.
- The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up.
- After metastasis, the first-line curative treatment is ineffective.
Who cannot join
- Patients who, for any reason, including severe psychological distress (as determined by the attending physician, psychiatrist, or specialist nurse based on assessments and impressions during routine patient care), cognitive impairment, or physical limitations (such as frailty), are unable to communicate or participate in an interview lasting more than 30 minutes.
Trial locations and contacts
1 site in 1 country.
Taiwan1 site, 1 recruiting
- Recruiting
National Taiwan University Hospital
Taipei, 100
Pei-Yu Hsu, +886-23123456 ext. 267940, 020854@ntuh.gov.tw
About this study
The purpose of this qualitative research is to use grounded theory to explore and describe the thoughts of young advanced cancer patients regarding end-of-life care and how these thoughts influence the related decision-making process.
- Conditions
- End-of-life Decision-making
- Keywords
- Young Patients, Advanced Cancer, Grounded Theory
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Young Patients With Advanced Cancer | 1. The patient has a solid tumor. 2. The age at initial cancer diagnosis is between 15 and 39 years. 3. The patient is at least 18 years old at the time of enrollment. 4. The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up. 5. After metastasis, the first-line curative treatment is ineffective. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Interview Guide
1.The journey since diagnosis. 2. The most profound or recent medical decision. 3. The most profound or recent medical decision. 4. Anticipated future medical decisions. 5. Future end-of-life care options
Measured: 2024/7~2025/7
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Aug 2024
- Study start23 Jul 2024
- Primary completionJul 2025 (estimated)
- Study completionJul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End-of-life Decision-makingStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06551831
- Sponsor's protocol ID
- 202406142RINE
- Status last verified
- Aug 2024
- First submitted
- 4 Aug 2024
- Last updated
- 13 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach
- ClinicalTrials.gov ID
- NCT06551831
- Acronym / sponsor ID
- 202406142RINE
- Conditions
- End-of-life Decision-making
- Keywords
- Young Patients, Advanced Cancer, Grounded Theory
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 23 Jul 2024 (actual)
- Primary completion
- Jul 2025 (estimated)
- Study completion
- Jul 2025 (estimated)
- First posted
- 13 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this qualitative research is to use grounded theory to explore and describe the thoughts of young advanced cancer patients regarding end-of-life care and how these thoughts influence the related decision-making process.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Young Patients With Advanced Cancer | – | –1. The patient has a solid tumor. 2. The age at initial cancer diagnosis is between 15 and 39 years. 3. The patient is at least 18 years old at the time of enrollment. 4. The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up. 5. After metastasis, the first-line curative treatment is ineffective. |
Who may qualify
- Ages
- 18 to 39 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- * The patient has a solid tumor. * The age at initial cancer diagnosis is between 15 and 39 years. * The patient is at least 18 years old at the time of enrollment. * The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up. * After metastasis, the first-line curative treatment is ineffective.
Key inclusion criteria (5 listed)
- The patient has a solid tumor.
- The age at initial cancer diagnosis is between 15 and 39 years.
- The patient is at least 18 years old at the time of enrollment.
- The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up.
- After metastasis, the first-line curative treatment is ineffective.
Key exclusion criteria (1 listed)
- Patients who, for any reason, including severe psychological distress (as determined by the attending physician, psychiatrist, or specialist nurse based on assessments and impressions during routine patient care), cognitive impairment, or physical limitations (such as frailty), are unable to communicate or participate in an interview lasting more than 30 minutes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Interview Guide
Time frame: 2024/7~2025/7
1.The journey since diagnosis. 2. The most profound or recent medical decision. 3. The most profound or recent medical decision. 4. Anticipated future medical decisions. 5. Future end-of-life care options
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2024.
- Individual participant dataSharing planned: No
Related trials for End-of-life Decision-making
Recruiting
A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions
Dementia Caregivers, End of Life Decision Making
RecruitingObservational study
Life Sustaining Treatments in Critically Ill Children
Critical Illness, Ethics
Active, not recruitingObservational study
Parental Decision-Making for Children With Relapsed Neuroblastoma
Relapsed Neuroblastoma
Active, not recruiting
LEADing Dementia End-of-Life Planning Conversations
Alzheimer Disease, Mild Cognitive Impairment
Not yet recruitingObservational study
Impact of Parental Presence at the Ethics Meeting in Neonatal Intensive Care
Parental Presence, Pediatric Ethics Consultation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of End-of-life Decision-making, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Pei-Yu Hsu (+886-23123456 ext. 267940, 020854@ntuh.gov.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Interview Guide (time frame: 2024/7~2025/7). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2024.